Quality Control and Troubleshooting Arista Biologicals Inc.

Slides:



Advertisements
Similar presentations
CAP/POCT 2003 Carol Riley-Hunte, RRT Senior Education Specialist Bayer HealthCare.
Advertisements

WHO - PSM Documentation – Part 2 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm.
© WHO – PSM Quality Control Laboratory Pharmaceutical Quality, Good manufacturing Practice & Bioequivalence Kiev, Ukraine October 2005 Maija Hietava.
Transdermal Drug Delivery Systems Amit K. Mitra, Ph.D ONDC, CDER.
MANUFACTURING DOCUMENTS.
Legal Defensibility in the Laboratory To Protect and Enhance Kentucky’s Environment KWWOA April 17, 2013.
Troubleshooting: ELISA & rapid may troubleshooting: ELISA may 2005.
Stability data required by WHO-PQP Mercy Acquaye.
Good Manufacturing Practices Guilin, PRC Dr AJ van Zyl for Quality Assurance and Safety: Medicines Medicines Policy and Standards Health Technology and.
This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download, adapt, and distribute this.
QC | Slide 1 of 21 June 2006 Good Practices for Quality Control Laboratories Part 2: Materials and set-up of equipment, instruments and other devices Supplementary.
Guidelines for the Development of Process Specifications, Instructions, and Controls for the Fabrication of Fiber-Reinforced Polymer Composites by Liquid.
World Health Organization
World Health Organization
SAE AS9100 Quality Systems - Aerospace Model for Quality Assurance
Module 12 – part 2 | Slide 1 of 35 January 2006 Basic Principles of GMP Documentation Part 2 15.
Dr Samah Kotb Lecturer of Biochemistry 1 CLS 432 Dr. Samah Kotb Nasr El-deen Biochemistry Clinical practice CLS 432 Dr. Samah Kotb Nasr.
Quality Management System
This teaching material has been made freely available by the KEMRI-Wellcome Trust (Kilifi, Kenya). You can freely download, adapt, and distribute this.
3-1 Select Measures Use SPC to Maintain Current Process Collect & Interpret Data Select Measures Define Process Is Process Capable ? Improve Process Capability.
Supplementary Training Modules on Good Manufacturing Practice
Quality control of raw materials In-process control
Supplementary Training Modules on Good Manufacturing Practice
ISO 9000 Certification ISO 9001 and ISO
UNIT 3.04 Career Opportunities By PresenterMedia.comPresenterMedia.com.
World Health Organization
Kyiv, TRAINING WORKSHOP ON PHARMACEUTICAL QUALITY, GOOD MANUFACTURING PRACTICE & BIOEQUIVALENCE Validation of Analytical Methods Used For Bioequivalence.
QC | Slide 1 of 16 June 2006 Good Practices for Quality Control Laboratories P art 4: Inspecting the laboratory Supplementary Training Modules on Good.
Documentation –Part 2 Basic Principles of GMP Pharmaceutical Quality,
Field Analysis Quality Control
World Health Organization
Introduction to Equipment
Basic Principles of GMP
Accelerated Stability Testing
Rocky Mountain RAPS Process Validation Presentation 6/7/06 By Clay Anselmo.
PRODUCTION PROCESS SchedulingInventory Incoming QC BinningPre-assemblyCalibration Final Assembly Final QA Packaging & Shipping.
Inspection Issues in the Analytical Laboratory: An FDA Perspective Yvonne McKnight Chemist US Food and Drug AdministrationPhone: x
ELISA Equipment. INTRODUCTION TO ELISA ELISA, or Enzyme-Linked Immunosorbent Assay, are immunological procedures used to determine the presence of antibodies.
Guidelines, Equipment and Supplies for Sterile Compounding
Important informations
Development of Prostatic Exosomal Protein Lateral Flow Chromatographic Strips for Detection of Chronic Prostatitis Jiao Zhang MD, PhD. The Brody School.
Aloe Vera of America: A Quality IASC-Certified Producer of Aloe Vera Presented by Walt Jones.
Leukocyte-Reduced Blood Components Lore Fields MT(ASCP)SBB Consumer Safety Officer, DBA, OBRR, CBER September 16, 2009.
30/02/2008 Dept. of Pharmaceutics 1 Salient Features of Quality Assurance Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D Associate Professor Department of Pharmaceutics.
Biochemistry Clinical practice CLS 432 Dr. Samah Kotb Lecturer of Biochemistry 2015 Introduction to Quality Control.
Developing Real World Tests and Assays Using Gold Particles Arista Biologicals Inc.
QC/QA.
Validation Defination Establishing documentary evidence which provides a high degree of assurance that specification process will consistently produce.
Sterile product validation
Module 14Slide 1 of 23 WHO - EDM Basic Principles of GMP Active Pharmaceutical Ingredients Part Three, 18.
Module 12 - part 2Slide 1 of 23 WHO - EDM Basic Principles of GMP Documentation Part 2 Part One, 14.
Pharmaceutical Quality Control & current Good Manufacturing Practice PHT 436 Lecture 8 1.
Pharmaceutical Quality Control & current Good Manufacturing Practice
Awareness Training: ‘HARPC’ for Food Safety Complimentary Presentation by Quality Systems Enhancement 1790 Wood Stock Road Roswell GA E. mail:
Major Aspects of Detector Reagents Arista Biologicals Inc.
SEMINAR ON PRESENTED BY BRAHMABHATT BANSARI K. M. PHARM PART DEPARTMENT OF PHARMACEUTICS AND PHARMACEUTICAL TECHNOLGY L. M. COLLEGE OF PHARMACY.
EQUIPMENT and METHOD VALIDATION
In the name of God. Common Technical Document On Biotech.
HOLD-TIME STUDIES.
Major Aspects of Detector Reagents
Pharmaceutical Quality Control & current Good Manufacturing Practice
The devices are shown before sample has been added
Lecture 6 Drying.
Pharmaceutical Quality Control & current Good Manufacturing Practice
Immunochromatography
Statistical Techniques
Documentation –Part 2 Basic Principles of GMP Pharmaceutical Quality,
College of Veterinary Medicine
Quality Assurance and Quality Control in Generics
Immunochromatography
Presentation transcript:

Quality Control and Troubleshooting Arista Biologicals Inc.

Quality Control Incoming Raw Materials QA/QC In Process QC Final Product Testing and Release Arista Biologicals Inc.

Development Process Product control is very important in both the research and development phase as well as in full production. Identify characteristics of components important for acceptable behavior in the test system Sensitivity Specificity Stability Test several lots in order to determine acceptable range of these characteristics in order to determine final raw material specifications. Arista Biologicals Inc.

Standard Operating Procedures Analytical methods (measurement techniques) Equipment operation, maintenance, and calibration Preproduction planning procedures Specific product procedures Product preparation In-process testing Raw materials acceptance procedures Storage and control Shipping and limitations Quality control and GMP compliance Validation of all the above Arista Biologicals Inc.

Incoming Raw Material Manufacturing Quarantine and sample all materials associated with the production of the final product. Verify specifications of raw materials by testing characteristic requirements defined in the development process. Maintain retention samples of raw material. Arista Biologicals Inc.

Typical Specifications for Materials used in Rapid Diagnostic Tests Membranes Wicking Rate (raw and processed) Length Thickness Protein Binding Capacity (functionality testing) Hydrophobicity (line quality and wetting) Overall Consistency thru lot (random sampling) Plastics Consistent dimensions No solvent leaching Color Flexibility Characteristics Arista Biologicals Inc.

Typical Specifications Cont… Conjugates and Antibodies Concentration Immunological Reactivity (functionality) Absorbents and Pads Density Thickness Hydrophobicity Consistency Arista Biologicals Inc.

Typical Specifications Cont… Desiccants Weight Moisture Content Moisture Capacity Indicator status (if applicable) Pouches Integrity Dimensions Arista Biologicals Inc.

Typical In Process Testing and Quality Control Documentation: Process and Control Instrument and Equipment Validation: pH meters, balances, dispensers, spectrophotometers, slitters, sealers, etc. Buffers: pH and conductivity measurements Reagent Concentration Verification: Verifying concentration of working dilutions. In Process Testing: Wicking rate, sensitivity, specificity, stability, etc., including within lot analysis and sampling. Parameters predetermined during the development stage and piloting. Arista Biologicals Inc.

Final Product Testing and Release Finished Product testing Accelerated Stability Studies and Tracking Final Documentation for Release Customer Complaints Arista Biologicals Inc.

General Troubleshooting Raw Materials Laminated Plastic Sheets Adhesive loses solvent which modifies membrane structure or immunological activity of reagents. Adhesive loses ability to bind to membrane or pads upon addition of liquid sample. Adhesive builds up excessively on strip cutter or slitter Sample and conjugate Pad Materials Inconsistent density or thickness causing flow problems or reagent capacity differences upon soaking of reagents. Hydrophobicity differences from lot to lot causing flow problems or nonspecific binding of reagents or sample. Fragile materials fracturing or fraying upon handling. Materials retaining analyte, conjugate, or other component of assay nonspecifically because of variation in pad material. Arista Biologicals Inc.

General Troubleshooting Cont… Raw Materials Cont.. Membranes Nonconsistent flow characteristics and/or pore size. Hydrophobic or hydrophilic behavior changes causing wetting, nonspecificity or line broadening problems. May be surfactant variation incorporated into the membrane either post or during membrane manufacturing. Protein capacity variation causing sensitivity changes. Inconsistent blocking causing flow or specificity problems. Conjugates and Antibodies Variation in sensitivity or specificity which may or may not be able to be compensated by concentration optimization. Release of conjugate variation and/or stability problems. Overloading of capture material or conjugate causing flow problems. Arista Biologicals Inc.

General Troubleshooting Cont… Raw Materials Cont… Equipment Dispenser not consistent within one continuous line or from sheet to sheet causing line quality and/or sensitivity or specificity problems. Dispenser causes inactivation of the reagent being dispensed onto membrane. Dispenser damaging membrane (contact systems) Drying not complete due to lack of moisture removing capability or capacity. Slitters or cutters damaging membrane causing structural damage to membrane or pads. Improper assembly or positioning of strip components causing flow problems ultimately causing assay failure. Improper assembly of strip to device causing flow problems also causing assay failure. Improper heat sealing of packaging causing stability problems. Arista Biologicals Inc.